Stock search

Ticker or company name

Compare stocks

Market: US

  • TECHBio-Techne
  • CRLCharles River Laboratories
  • RVTYRevvity

Add stock

Ticker or company

Summary

TECH
Bio-Techne
$72,79Down −0,01%
Year: Up +20%
69/100Best scoreRatio would watch
Open stock page
CRL
Charles River Laboratories
$335,52Down −0,72%
Year: Up +100%
50/100Ratio would watch
Open stock page
RVTY
Revvity
$148,85Down −3,59%
Year: Up +65%
56/100Ratio would watch
Open stock page

Verdict

TECH has the best score (69). RVTY grows revenue the fastest. RVTY is the cheapest by forward P/E. TECH has the lowest debt load. TECH has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckTECH4 ✓ 3 — 1 ✕CRL4 ✓ 1 — 4 ✕RVTY4 ✓ 2 — 3 ✕
P/E vs its history62,9403,068,1
P/E vs industry62,9403,068,1
Forward P/E34,229,527,1
Revenue growth, YoY+0,9%−1,2%+4,6%
EPS growth, YoY+122,4%—+13,1%
Net marginn/a—1,1%8,6%
Net debt / EBITDA−1,0−0,52,6
Free cash flow$308 m$400 m$590 m
Share count over a year+1,0%−1,7%−3,1%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterTECHTTMCRLTTMRVTYTTMIndustry medianTTM
P/E TTM ↓Best: 62,9Worst: 403,068,137,9
Forward P/E ↓Worst: 34,229,5Best: 27,129,5
PEG ↓Worst: 9,8n/aBest: 8,03,7
P/S TTM ↓Worst: 9,4Best: 4,15,96,6
EV/EBITDA ↓32,6Worst: 82,1Best: 25,829,9
P/FCF ↓Worst: 43,439,1Best: 29,238,7

Price, %

  • TECHn/a
  • CRLn/a
  • RVTYn/a

Returns

Best WorstNo mark — in between

PeriodTECHCRLRVTY
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

TECHCRLRVTY
Share of “buy”Worst: 0%Best: 77%44%
Beat the forecastWorst: 1 of 4Best: 4 of 4Best: 4 of 4
Average “surprise”Worst: −0,8%+4,5%Best: +6,7%
Insiders over 12 monthssales $437 178sales $52,1 msales $5,97 m

Details are on each stock page.